Amir Mortazavi

Exploring the impact of epigenetic modifications and experimental therapeutics, Dr. Amir Mortazavi serves as an Assistant Professor in the Department of Internal Medicine at The Ohio State University's College of Medicine and Public Health. With a specialization in hematology and oncology, Dr. Mortazavi is dedicated to advancing the understanding and treatment of genitourinary cancers through innovative research and clinical practice. Dr. Mortazavi's research focuses on the intricate mechanisms of epigenetic modifications and their potential role in the development and progression of genitourinary cancers. By investigating these molecular changes, he aims to identify novel therapeutic targets and develop experimental treatments that can improve patient outcomes. His work is pivotal in bridging the gap between laboratory discoveries and clinical applications, offering hope for more effective cancer therapies. In addition to his research endeavors, Dr. Mortazavi is committed to educating the next generation of medical professionals. He actively participates in teaching and mentoring medical students and residents, fostering a collaborative learning environment that encourages critical thinking and innovation. His dedication to both research and education underscores his commitment to improving patient care and advancing the field of oncology.